General Information of Drug Transporter (DT)
DT ID DTD0369 Transporter Info
Gene Name SLC45A2
Transporter Name Membrane-associated transporter protein
Gene ID
51151
UniProt ID
Q9UMX9
Post-Translational Modification of This DT
Overview of SLC45A2 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-N-glycosylation X-Phosphorylation X: Amino Acid

N-glycosylation

  Asparagine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC45A2 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

356

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC45A2 Asparagine 356 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC45A2 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

15

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC45A2 Serine 15 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC45A2 [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

24

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC45A2 Serine 24 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC45A2 [4] , [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

305

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC45A2 Serine 305 has the potential to affect its expression or activity.

  Threonine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC45A2 [6] , [7]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

108

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC45A2 Threonine 108 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC45A2 [6] , [7]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

125

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC45A2 Threonine 125 has the potential to affect its expression or activity.

  Tyrosine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC45A2 [6] , [7]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

105

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC45A2 Tyrosine 105 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC45A2 [6] , [7]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

120

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC45A2 Tyrosine 120 has the potential to affect its expression or activity.
References
1 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: S45A2_HUMAN)
2 A Phosphoproteomic Comparison of B-RAFV600E and MKK1/2 Inhibitors in Melanoma Cells. Mol Cell Proteomics. 2015 Jun;14(6):1599-615.
3 Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.
4 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
5 Determination of Site-Specific Phosphorylation Ratios in Proteins with Targeted Mass Spectrometry. J Proteome Res. 2018 Apr 6;17(4):1654-1663.
6 In situ sample processing approach (iSPA) for comprehensive quantitative phosphoproteome analysis. J Proteome Res. 2014 Sep 5;13(9):3896-904.
7 Characterization of native protein complexes and protein isoform variation using size-fractionation-based quantitative proteomics. Mol Cell Proteomics. 2013 Dec;12(12):3851-73.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.